Skip to main content
. 2018 Dec 18;9:2970. doi: 10.3389/fimmu.2018.02970

Table 1.

Oral infection of mice and passive administration of Abs.

PROPHYLACTIC SETTINGS
Bacterial infection assay
Mock-treated PBS 150 μl 2 × 107 St 100 μl
Ab-treated IgA/M/SCIgA/M/IgG 150 μl 2 × 107 St 100 μl
Mouse survival assay
Mock-treated PBS 150 μl 2 × 106 St 100 μl
Ab-treated IgA/M/SCIgA/M/IgG 150 μl 2 × 106 St 100 μl
THERAPEUTIC SETTINGS
Bacterial infection assay (treatment at + 1 h only)
Mock-treated PBS 150 μl 2 × 107 St 100 μl
Ab-treated SCIgA/M 150 μl 2 × 107 St 100 μl
Bacterial infection assay (treatment at + 1 h or + 8 h)
Mock-treated PBS 150 μl 2 × 106 St 100 μl
Ab-treated SCIgA/M 150 μl 2 × 106 St 100 μl
Mouse survival assay
Mock-treated PBS 150 μl 2 × 106 St 100 μl
Ab-treated SCIgA/M 150 μl 2 × 106 St 100 μl